Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Xiaomiao Lin"'
Autor:
Zhen-Bo Feng, Lu Liang, Xinggu Lin, Rong-Quan He, Dan-Dan Xiong, Rui-Xue Tang, Gang Chen, Kang-Lai Wei, Yi-Wu Dang, Xiaomiao Lin, Mengtong Jiang
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND DcR3 (decoy receptor 3) has been proposed be involved in development and prognosis of female reproductive cancers, including cervical cancer, ovarian cancer, and breast cancer. The purpose of this meta-analysis was to explore the evidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::537231e75411e12e9cedffe6486b4883
http://europepmc.org/articles/PMC4917315
http://europepmc.org/articles/PMC4917315
Autor:
Qian-Yi Huang, Xiaomiao Lin, Mu-Jun Li, Gang Chen, Ai-Hua Lan, Minhua Rong, Xinggu Lin, Rong-Quan He
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 4, p e0175501 (2017)
PLoS ONE, Vol 12, Iss 4, p e0175501 (2017)
Background Atosiban is administered to women undergoing in vitro fertilization-embryo transfer (IVF-ET) to improve pregnancy outcomes. However, the results of this treatment were controversial. We conducted this meta-analysis to investigate whether a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ebbce835bc57e3dddb4151213ee2bfa
http://europepmc.org/articles/PMC5396917
http://europepmc.org/articles/PMC5396917
Autor:
Mei-Lin Zhu, Shi-Tao Su, Yan-Xin Ling, Gang Chen, Madushi Mihiranganee Wickramaarachchi, Kang-Lai Wei, Xiaomiao Lin, Rong-Quan He, Deng-hua Pan, Xinggu Lin, Yi-Wu Dang
Publikováno v:
European Journal of Medical Research
Background Studies have been reported that cyclin-dependent kinase5 (CDK5) was associated with the development of several cancers. However, the relationship between CDK5 level and clinicopathological factors is still poorly understood in cervical dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cba84823442405e23c191df2a61f565
https://doi.org/10.1186/s40001-016-0222-0
https://doi.org/10.1186/s40001-016-0222-0
Autor:
Liyan Yan, Rong-Quan He, Hong Zhou, Gang Chen, Hui Qin, Hanlin Wang, Xiaomiao Lin, Xinggu Lin, Xiao-Ning Gan
Publikováno v:
Disease Markers
Disease Markers, Vol 2016 (2016)
Disease Markers, Vol 2016 (2016)
p16, encoded by theCDKN2Agene, is a tumor suppressor that has been widely studied in cancer research. However, the relationship of p16 with prognostic and clinicopathological parameters in patients with bladder cancer remains unclear. Data inclusion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72f43044ec593a00dfa8a17cb518487f
http://europepmc.org/articles/PMC4854991
http://europepmc.org/articles/PMC4854991